NYSE:PRGO - Perrigo Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $56.99 -1.52 (-2.60 %) (As of 12/16/2018 04:00 PM ET)Previous Close$56.99Today's Range$56.88 - $58.2352-Week Range$56.88 - $95.93Volume1.58 million shsAverage Volume1.04 million shsMarket Capitalization$7.74 billionP/E Ratio11.56Dividend Yield1.33%Beta0.58 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Receive PRGO News and Ratings via Email Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNYSE:PRGO Previous Symbol CUSIP71429010 Webwww.perrigo.com Phone353-1709-4000 Debt Debt-to-Equity Ratio0.54 Current Ratio1.85 Quick Ratio1.26 Price-To-Earnings Trailing P/E Ratio11.56 Forward P/E Ratio12.53 P/E Growth2.05 Sales & Book Value Annual Sales$4.95 billion Price / Sales1.57 Cash Flow$7.9930 per share Price / Cash Flow7.13 Book Value$43.81 per share Price / Book1.30 Profitability EPS (Most Recent Fiscal Year)$4.93 Net Income$119.60 million Net Margins2.54% Return on Equity11.32% Return on Assets5.96% Miscellaneous Employees10,400 Outstanding Shares135,860,000Market Cap$7.74 billion OptionableOptionable Perrigo (NYSE:PRGO) Frequently Asked Questions What is Perrigo's stock symbol? Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO." How often does Perrigo pay dividends? What is the dividend yield for Perrigo? Perrigo announced a quarterly dividend on Wednesday, October 31st. Investors of record on Friday, November 30th will be paid a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Thursday, November 29th. View Perrigo's Dividend History. How were Perrigo's earnings last quarter? Perrigo Company PLC (NYSE:PRGO) posted its quarterly earnings data on Thursday, November, 8th. The company reported $1.09 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.04. The firm earned $1.13 billion during the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a net margin of 2.54% and a return on equity of 11.32%. The firm's revenue was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.39 earnings per share. View Perrigo's Earnings History. When is Perrigo's next earnings date? Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo. What guidance has Perrigo issued on next quarter's earnings? Perrigo issued an update on its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS. What price target have analysts set for PRGO? 15 equities research analysts have issued twelve-month price targets for Perrigo's stock. Their forecasts range from $63.00 to $110.00. On average, they expect Perrigo's share price to reach $82.00 in the next year. This suggests a possible upside of 43.9% from the stock's current price. View Analyst Price Targets for Perrigo. What is the consensus analysts' recommendation for Perrigo? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo. Has Perrigo been receiving favorable news coverage? Headlines about PRGO stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a daily sentiment score of 1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. Who are some of Perrigo's key competitors? Some companies that are related to Perrigo include ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Mylan (MYL), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Genmab A/S (GNMSF), Jazz Pharmaceuticals (JAZZ), Bausch Health Companies (BHC) and Sarepta Therapeutics (SRPT). Who are Perrigo's key executives? Perrigo's management team includes the folowing people: Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)Mr. Sharon Kochan, Exec. VP & Pres of Branded Consumer Healthcare and International (Age 50)Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)Mr. Murray S. Kessler, CEO, Pres & Director (Age 58) Who are Perrigo's major shareholders? Perrigo's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc (10.36%), Vanguard Group Inc. (10.36%), FMR LLC (8.10%), Franklin Resources Inc. (6.79%), BlackRock Inc. (6.08%) and Brown Brothers Harriman & Co. (4.13%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo. Which institutional investors are selling Perrigo stock? PRGO stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., Brown Brothers Harriman & Co., Deutsche Bank AG, Migdal Insurance & Financial Holdings Ltd., Crawford Investment Counsel Inc. and Panagora Asset Management Inc.. View Insider Buying and Selling for Perrigo. Which institutional investors are buying Perrigo stock? PRGO stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Iridian Asset Management LLC CT, Ceredex Value Advisors LLC, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, First Eagle Investment Management LLC, Nordea Investment Management AB, Franklin Resources Inc. and Victory Capital Management Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo. How do I buy shares of Perrigo? Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Perrigo's stock price today? One share of PRGO stock can currently be purchased for approximately $56.99. How big of a company is Perrigo? Perrigo has a market capitalization of $7.74 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe. What is Perrigo's official website? The official website for Perrigo is http://www.perrigo.com. How can I contact Perrigo? Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected] MarketBeat Community Rating for Perrigo (NYSE PRGO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 641 (Vote Outperform)Underperform Votes: 607 (Vote Underperform)Total Votes: 1,248MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/16/2018 by MarketBeat.com StaffFeatured Article: What are different types of coverage ratios?